Fidelity's passive stake is unchanged at 10.7%. No signal of increased conviction or exit. Monitor next filing for any change in position or conversion to 13D.
VOR drugs
VOR drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5- T+0 · Nov 5 $18.66entry
- T+1 · 11d ago +6.54%α +6.23% · $19.88
- T+5 · 5d ago +3.54%α +0.25% · $19.32
- T+7 · todayOpen
- T+20 · in 17d Pending
- T+60 · in 3mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
FMR LLC (Fidelity) filed an amended Schedule 13G disclosing beneficial ownership of 6,318,525 shares of Vor Biopharma common stock as of September 30, 2026, representing 10.7% of shares outstanding. This is an increase from the prior filing (6,318,525 shares vs. 6,318,525 shares at July 31, 2026), the stake is unchanged. Fidelity remains a passive holder above the 5% threshold.
Key Financial Metrics
Key Facts
- FMR LLC (Fidelity) reported beneficial ownership of 6,318,525 shares of Vor Biopharma common stock as of September 30, 2026.
- The stake represents 10.7% of shares outstanding.
- This is an amendment to Schedule 13G, confirming passive investment intent.
- The stake is unchanged from the prior filing (6,318,525 shares as of July 31, 2026).
- Fidelity Management & Research Company LLC is the entity beneficially owning 5% or greater.
Financial Impact
Stake valued at approximately $128.4M based on $1.2B market cap and 10.7% ownership.
Risk Factors
- Fidelity could reduce its stake in future periods, potentially pressuring the stock.
- Passive filing status means no activist intent is signaled.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G/A Filing (Primary) | 0000315066-26-002877 |
| Document: 0000315066-26-002877-index-headers.html | 0000315066-26-002877 |
| Document: 0000315066-26-002877-index.html | 0000315066-26-002877 |
| Document: 0000315066-26-002877.txt | 0000315066-26-002877 |
Track record
17 reports on VOR
3 of 4 bullish or bearish reports moved the stock their way by T+1. Best: +70.35% at T+60 after the Jun 8, 2026 report. 4 of 4 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $18.97 Now $18.97 −0.00% settles Nov 18
- Nov 12, 20264d ago 8-K Neutral 5/10 Entry $19.32 to $19.42 Now $18.97 −1.81% ▲ +0.52% +0.88% vs SPY
- Nov 5, 202611d ago SC 13G/A Neutral 2/10 Viewing Entry $18.66 to $19.88 Now $18.97 +1.66% ▲ +6.54% +6.23% vs SPY
- Oct 30, 202617d ago 424B5 Bearish 4/10 Entry $19.68 to $19.25 Now $18.97 +3.61% ▲ +2.19% +1.71% vs SPY
- Oct 30, 202617d ago Press Release Neutral 4/10 Entry $19.68 to $19.25 Now $18.97 −3.61% ▼ −2.19% −1.71% vs SPY
- Oct 22, 202625d ago Press Release Bullish 7/10 Entry $18.26 to $18.33 Now $18.97 +3.89% ▲ +0.38% −0.33% vs SPY
- Oct 5, 20266w ago Press Release Neutral 2/10 Entry $18.31 to $18.78 Now $18.97 +3.60% ▲ +2.57% +2.81% vs SPY
- Sep 29, 20266w ago Press Release Bullish 6/10 Entry $18.33 to $19.08 Now $18.97 +3.49% ▲ +4.09% +4.30% vs SPY
- Aug 11, 202613w ago Press Release Neutral 3/10 Entry $23.37 to $22.34 Now $18.97 −18.83% ▼ −4.41% −4.66% vs SPY
- Jul 9, 202618w ago 3 Neutral 2/10 Entry $19.14 to $18.03 Now $18.97 −0.89% ▼ −5.80% −5.03% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers